EI Earnings Insight Lab
JNJ / NYSE

Johnson & Johnson

Healthcare Drug Manufacturers - Major 25 earnings pages
Company site

Johnson & Johnson engages in the research and development, manufacture, and sale of various products in the health care field worldwide. The company operates in three segments: Consumer, Pharmaceutical, and Medical Devices and Diagnostics.

Latest snapshot
Q 2025
Latest revenue
$94.2B
Latest EPS
$11.03
Market cap
$0
Location
New Brunswick, New Jersey
Recent coverage

Recent earnings pages for Johnson & Johnson

See filtered archive
Q 2025 / Filed 2026-02-11

Johnson & Johnson Q 2025 earnings

Revenue
$94.2B
EPS
$11.03
Revenue YoY
+6%
Q4 2025 / Filed 2026-02-11

Johnson & Johnson Q4 2025 earnings

Revenue
$24.6B
EPS
$2.10
Revenue YoY
+9.1%
Q3 2025 / Filed 2025-10-22

Johnson & Johnson Q3 2025 earnings

Revenue
$24.0B
EPS
$2.12
Revenue YoY
+6.8%
Q2 2025 / Filed 2025-07-24

Johnson & Johnson Q2 2025 earnings

Revenue
$23.7B
EPS
$2.29
Revenue YoY
+5.8%
Q1 2025 / Filed 2025-04-23

Johnson & Johnson Q1 2025 earnings

Revenue
$21.9B
EPS
$4.54
Revenue YoY
+2.4%
Q 2024 / Filed 2025-02-13

Johnson & Johnson Q 2024 earnings

Revenue
$88.8B
EPS
$5.79
Revenue YoY
+4.3%
Q4 2024 / Filed 2025-02-13

Johnson & Johnson Q4 2024 earnings

Revenue
$22.5B
EPS
$1.41
Revenue YoY
+5.3%
Q3 2024 / Filed 2024-10-23

Johnson & Johnson Q3 2024 earnings

Revenue
$22.5B
EPS
$1.11
Revenue YoY
+5.2%
Q2 2024 / Filed 2024-07-25

Johnson & Johnson Q2 2024 earnings

Revenue
$22.4B
EPS
$1.93
Revenue YoY
+4.3%
Q1 2024 / Filed 2024-05-01

Johnson & Johnson Q1 2024 earnings

Revenue
$21.4B
EPS
$1.34
Revenue YoY
+2.3%
Q 2023 / Filed 2024-02-16

Johnson & Johnson Q 2023 earnings

Revenue
$85.2B
EPS
$13.72
Revenue YoY
+6.5%
Q4 2023 / Filed 2024-02-16

Johnson & Johnson Q4 2023 earnings

Revenue
$21.4B
EPS
$1.67
Revenue YoY
-9.7%
0.052485s